Fengqi Nie

3.1k total citations · 1 hit paper
28 papers, 2.2k citations indexed

About

Fengqi Nie is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Fengqi Nie has authored 28 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 24 papers in Cancer Research and 2 papers in Oncology. Recurrent topics in Fengqi Nie's work include Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (17 papers) and RNA Research and Splicing (11 papers). Fengqi Nie is often cited by papers focused on Cancer-related molecular mechanisms research (24 papers), RNA modifications and cancer (17 papers) and RNA Research and Splicing (11 papers). Fengqi Nie collaborates with scholars based in China, United States and Canada. Fengqi Nie's co-authors include Ming Sun, Zhaoxia Wang, Wei De, Min Xie, Chenchen Wei, Kaihua Lu, Yunfei Wang, Qinnan Chen, Zhenyao Chen and Xiang-hua Liu and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and Molecular Cancer.

In The Last Decade

Fengqi Nie

28 papers receiving 2.1k citations

Hit Papers

LncRNA HOXA11-AS Promotes Proliferation and Invasion of G... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fengqi Nie China 22 1.9k 1.9k 153 114 111 28 2.2k
Xuezhi He China 22 1.6k 0.8× 1.6k 0.8× 154 1.0× 164 1.4× 101 0.9× 30 1.8k
Chenchen Wei China 17 1.2k 0.6× 1.2k 0.6× 85 0.6× 61 0.5× 94 0.8× 28 1.4k
Anbang He China 24 1.3k 0.7× 1.2k 0.6× 81 0.5× 209 1.8× 186 1.7× 54 1.6k
Zhongqiu Lin China 17 780 0.4× 754 0.4× 114 0.7× 56 0.5× 49 0.4× 37 1.1k
Qiongyan Zhang China 16 634 0.3× 537 0.3× 62 0.4× 124 1.1× 158 1.4× 27 972

Countries citing papers authored by Fengqi Nie

Since Specialization
Citations

This map shows the geographic impact of Fengqi Nie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fengqi Nie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fengqi Nie more than expected).

Fields of papers citing papers by Fengqi Nie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fengqi Nie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fengqi Nie. The network helps show where Fengqi Nie may publish in the future.

Co-authorship network of co-authors of Fengqi Nie

This figure shows the co-authorship network connecting the top 25 collaborators of Fengqi Nie. A scholar is included among the top collaborators of Fengqi Nie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fengqi Nie. Fengqi Nie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nie, Fengqi, Yu‐Li Chen, Peng Huang, et al.. (2024). TREM1/DAP12 based novel multiple chain CAR‐T cells targeting DLL3 show robust anti‐tumour efficacy for small cell lung cancer. Immunology. 172(3). 362–374. 9 indexed citations
2.
Yu, Tao, Fengqi Nie, Qi Zhang, et al.. (2024). Effects of methionine deficiency on B7H3-DAP12-CAR-T cells in the treatment of lung squamous cell carcinoma. Cell Death and Disease. 15(1). 12–12. 12 indexed citations
3.
Yu, Tao, Qi Zhang, Fengqi Nie, et al.. (2023). THOC3 interacts with YBX1 to promote lung squamous cell carcinoma progression through PFKFB4 mRNA modification. Cell Death and Disease. 14(7). 475–475. 23 indexed citations
4.
Xu, Yongcan, Jing Xu, Jun Lü, et al.. (2022). LncRNA RP11-138J23.1 Contributes to Gastric Cancer Progression by Interacting With RNA-Binding Protein HuR. Frontiers in Oncology. 12. 848406–848406. 5 indexed citations
5.
Chen, Xin, Zhenyao Chen, Hao Wu, et al.. (2021). Comprehensive Genomic Characterization Analysis Identifies an Oncogenic Pseudogene RP11-3543B.1 in Human Gastric Cancer. Frontiers in Cell and Developmental Biology. 9. 743652–743652. 4 indexed citations
6.
Chen, Xin, Zhenyao Chen, Shanxun Yu, et al.. (2018). Long Noncoding RNA LINC01234 Functions as a Competing Endogenous RNA to Regulate CBFB Expression by Sponging miR-204-5p in Gastric Cancer. Clinical Cancer Research. 24(8). 2002–2014. 183 indexed citations
7.
Xu, Yongcan, Xiang Yu, Chenchen Wei, et al.. (2018). Over-expression of oncigenic pesudogene DUXAP10 promotes cell proliferation and invasion by regulating LATS1 and β-catenin in gastric cancer. Journal of Experimental & Clinical Cancer Research. 37(1). 13–13. 33 indexed citations
8.
Liu, Zhili, Zhenyao Chen, Ruihua Fan, et al.. (2017). Over-expressed long noncoding RNA HOXA11-AS promotes cell cycle progression and metastasis in gastric cancer. Molecular Cancer. 16(1). 82–82. 137 indexed citations
9.
Qi, Fuzhen, Xiang-hua Liu, Hao Wu, et al.. (2017). Long noncoding AGAP2-AS1 is activated by SP1 and promotes cell proliferation and invasion in gastric cancer. Journal of Hematology & Oncology. 10(1). 48–48. 109 indexed citations
10.
Chen, Zhenyao, Xin Chen, Ping Chen, et al.. (2017). Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death and Disease. 8(10). e3092–e3092. 92 indexed citations
11.
Yang, Li, Xiang He, Liang Chen, et al.. (2017). Placenta-specific protein 1 promotes cell proliferation and invasion in non-small cell lung cancer. Oncology Reports. 39(1). 53–60. 21 indexed citations
12.
Sun, Ming, Fengqi Nie, Yunfei Wang, et al.. (2016). LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1. Cancer Research. 76(21). 6299–6310. 405 indexed citations breakdown →
13.
Ma, Pei, Meiling Zhang, Fengqi Nie, et al.. (2016). Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 87. 20–26. 39 indexed citations
14.
Sun, Ming, Fengqi Nie, Zhaoxia Wang, & Wei De. (2016). Involvement of lncRNA dysregulation in gastric cancer.. PubMed. 31(1). 33–9. 59 indexed citations
15.
Xie, Min, Fengqi Nie, Ming Sun, et al.. (2015). Decreased long noncoding RNA SPRY4-IT1 contributing to gastric cancer cell metastasis partly via affecting epithelial–mesenchymal transition. Journal of Translational Medicine. 13(1). 250–250. 88 indexed citations
16.
Shi, Xuefei, Fengqi Nie, Zhaoxia Wang, & Ming Sun. (2015). Pseudogene-expressed RNAs: a new frontier in cancers. Tumor Biology. 37(2). 1471–1478. 32 indexed citations
17.
Nie, Fengqi, Shijie Ma, Min Xie, et al.. (2015). Decreased long noncoding RNA MIR31HG is correlated with poor prognosis and contributes to cell proliferation in gastric cancer. Tumor Biology. 37(6). 7693–7701. 38 indexed citations
19.
Nie, Fengqi, Quan Zhu, Tongpeng Xu, et al.. (2014). Long non-coding RNA MVIH indicates a poor prognosis for non-small cell lung cancer and promotes cell proliferation and invasion. Tumor Biology. 35(8). 7587–7594. 82 indexed citations
20.
Zhang, Meiling, Fengqi Nie, Ming Sun, et al.. (2014). HOXA5 indicates poor prognosis and suppresses cell proliferation by regulating p21 expression in non small cell lung cancer. Tumor Biology. 36(5). 3521–3531. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026